-
Loading metrics
A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury
- Pavel I. Pilipenko,
- Anna A. Ivanova,
- Yulia V. Kotsiubinskaya,
- Vera N. Grigoryeva,
- Alexey Y. Khrulev,
- Anatoly V. Skorokhodov,
- Maxim M. Gavrik,
- Nona N. Mkrtchan,
- Marek Majdan,
- Peter Valkovic
x
- Published: July 10, 2025
- https://doi.org/10.1371/journal.pone.0310229